Skip to content
Dosage GuideResearch Reference

Kisspeptin-10 Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Kisspeptin-10. All information is for educational purposes only.

Quick Answer

Clinical research suggests that kisspeptin-10 is typically administered in doses ranging from 0.5 to 2.5 mcg/kg via subcutaneous injection. Single doses are often used for diagnostic purposes (e.g., pubertal disorders), while repeat doses are investigated for fertility treatments and sexual desire enhancement. Dosing frequency and duration vary depending on the specific research protocol. Human clinical dose-ranging trials are ongoing.

→ Kisspeptin-10 Benefits→ Kisspeptin-10 Side Effects→ Full Kisspeptin-10 Profile
Table of Contents

Standard Dosage Range

Research dosing range: 0.5–2.5 mcg/kg

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Diagnostic Testing (Pubertal Disorders)

1 mcg/kgSingle dose
Duration

Single administration

Subcutaneous injection used for kisspeptin challenge tests to assess HPG axis function. Helps differentiate between hypothalamic amenorrhea and other causes of pubertal delay.

Fertility Treatment (IVF Trigger)

1–2.5 mcg/kgSingle dose
Duration

Single administration

Subcutaneous injection to trigger oocyte maturation as an alternative to hCG. Aims to reduce the risk of ovarian hyperstimulation syndrome (OHSS).

Sexual Desire Enhancement

0.5-1 mcg/kgSingle dose
Duration

Single administration

Subcutaneous injection. Studied for acute effects on brain activity in reward and sexual arousal centers. More research is needed on optimal dosing and long-term effects.

Research Purposes (HPG Axis Stimulation)

Varies (0.5 - 2.5 mcg/kg)Varies (Single or multiple doses)
Duration

Variable depending on study protocol

Used in research settings to stimulate LH and FSH release and study the effects on reproductive hormone levels.

Timing & Frequency

For diagnostic purposes, timing is less critical. For fertility treatments, it is administered at a specific point in the IVF cycle. For sexual desire enhancement, timing relative to sexual activity is being investigated. Due to its short half-life, sustained effects likely require frequent administration or continuous infusion, which are not standard practices.

Cycle Guidance

Clinical studies have primarily used single-dose administration or short-term (days) dosing protocols. The long-term effects of repeated kisspeptin-10 administration are not well-understood. Cautious use is advised until further research is available. Cycling is not currently a common practice.

Reconstitution Reference

Quick reference for reconstituting Kisspeptin-10. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically supplied in lyophilized form (e.g., 100 mcg per vial).
BAC Water VolumeVaries depending on desired concentration. For example, 1 mL bacteriostatic water for 100 mcg/mL concentration.
Concentration & DrawExample: At 100 mcg/mL: 1 mcg = 0.01 mL (1 unit on a 100-unit insulin syringe)
StorageRefrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
StabilityReconstituted solution stable for a limited time (consult manufacturer guidelines). Lyophilized powder stable for a longer period per manufacturer specifications.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the typical kisspeptin-10 dosage for fertility treatment?
Clinical trials have explored dosages of 1-2.5 mcg/kg as a single subcutaneous injection to trigger oocyte maturation in IVF. The goal is to provide a safer alternative to hCG with a reduced risk of OHSS.
How is kisspeptin-10 administered?
Kisspeptin-10 is typically administered via subcutaneous injection.
What are the potential benefits of kisspeptin-10?
Potential benefits include stimulation of natural hormone production, improved diagnostic accuracy for pubertal disorders, and potential enhancement of sexual desire. It may offer a safer approach to triggering ovulation in IVF.
What is the half-life of kisspeptin-10?
The half-life of kisspeptin-10 is relatively short, approximately 28 minutes.

Last updated: 2026-02-19